Related references
Note: Only part of the references are listed.Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling
Siyang Wen et al.
CANCER LETTERS (2019)
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Systemic Treatment for Advanced Hepatocellular Carcinoma
Mohamed Bouattour et al.
LIVER CANCER (2019)
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity
Pei-Ju Sung et al.
CANCER RESEARCH (2019)
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
Masahiro Shibata et al.
CANCERS (2019)
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
Shaoqiang Cheng et al.
CANCER BIOLOGY & THERAPY (2019)
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Briana C. Prager et al.
CELL STEM CELL (2019)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis
Madelon Paauwe et al.
CLINICAL CANCER RESEARCH (2018)
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
Man Tong et al.
JOURNAL OF HEPATOLOGY (2018)
Cell type specific expression of Follistatin-like 1 (Fstl1) in mouse embryonic lung development
Xue Liu et al.
JOURNAL OF MOLECULAR HISTOLOGY (2018)
Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-beta 1 secretion
Yu Ren et al.
MOLECULAR CANCER (2018)
FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway
Chuansha Gu et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Follistatin-like protein 1 sustains colon cancer cell growth and survival
Gerolamo Bevivino et al.
Oncotarget (2018)
PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Sternness Activities in Hepatocellular Carcinoma through CRAF Methylation
Lok Hei Chan et al.
CELL REPORTS (2018)
A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma
Baojia Zou et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma
Yan Liu et al.
CHINESE JOURNAL OF CANCER (2018)
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis
Pin Liu et al.
HEPATOLOGY (2017)
FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3 β dependent manner in hepatocellular carcinoma
Wei Yang et al.
CANCER BIOMARKERS (2017)
FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk
Marco Chi-Chung Lau et al.
CANCER RESEARCH (2017)
TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts
Xiaohong Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
TLR4 signaling promotes a COX-2/PGE(2)/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells
Ang Lin et al.
ONCOIMMUNOLOGY (2016)
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture
Sonomi Maruyama et al.
EMBO MOLECULAR MEDICINE (2016)
Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling
Eunice Yuen Ting Lau et al.
CELL REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
Yingying Dong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Xin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
MYC Activates Stem-like Cell Potential in Hepatocarcinoma by a p53-Dependent Mechanism
Hirofumi Akita et al.
CANCER RESEARCH (2014)
Role of Myc in hepatocellular proliferation and hepatocarcinogenesis
Aijuan Qu et al.
JOURNAL OF HEPATOLOGY (2014)
The Long Non-Coding RNA GAS5 Cooperates with the Eukaryotic Translation Initiation Factor 4E to Regulate c-Myc Translation
Guangzhen Hu et al.
PLOS ONE (2014)
Follistatin-Like 1 Attenuates Apoptosis via Disco-Interacting Protein 2 Homolog A/Akt Pathway After Middle Cerebral Artery Occlusion in Rats
Xiping Liang et al.
STROKE (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
Daria Capece et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Akihiro Tsuyada et al.
CANCER RESEARCH (2012)
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4
Kosaku Murakami et al.
FEBS LETTERS (2012)
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways
Coral Ho et al.
HEPATOLOGY (2012)
Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
Edward Kai-Hua Chow et al.
HEPATOLOGY (2012)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development
Yan Geng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
DIP2A Functions as a FSTL1 Receptor
Noriyuki Ouchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen et al.
NATURE CELL BIOLOGY (2010)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
Follistatin-like protein-1 is a novel proinflammatory molecule
Takako Miyamae et al.
JOURNAL OF IMMUNOLOGY (2006)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Immortal activated human hepatic stellate cells generated by ectopic telomerase expression
B Schnabl et al.
LABORATORY INVESTIGATION (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Share Paper
